Qyuns Therapeutics Co., Ltd.
Status: Publicly traded
Direct answer
Qyuns Therapeutics Co., Ltd. is publicly traded on HKSE under the ticker 2509.HK.
Qyuns Therapeutics Co., Ltd., a biotechnology company established in 2015 and headquartered in Taizhou, China, is focused on the discovery and clinical advancement of biologic therapies. Its primary mission is to address autoimmune and allergic diseases within the People's Republic of China. The company boasts a robust pipeline of investigational treatments. Its lead candidate, QX002N, an interleukin (IL)-17A...
Can you invest in Qyuns Therapeutics Co., Ltd.?
Yes. Qyuns Therapeutics Co., Ltd. is publicly traded on HKSE under the ticker 2509.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Qyuns Therapeutics Co., Ltd.
Detailed equity research is provided by MarketSnap.